Yüklüyor......
Cost-effectiveness of Transplanting HCV-Infected Livers into Uninfected Recipients with Preemptive Antiviral Therapy
BACKGROUND & AIMS: Guidelines do not recommend transplanting hepatitis C virus (HCV)-infected livers into HCV-uninfected recipients. Direct-acting antivirals (DAAs) can be used to treat donor-derived HCV infection. However the added cost of DAA therapy is a barrier. We evaluated the cost effecti...
Kaydedildi:
| Yayımlandı: | Clin Gastroenterol Hepatol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382534/ https://ncbi.nlm.nih.gov/pubmed/30138735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2018.08.042 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|